£83.40

This is the most expensive it has ever been. Walk away.

£83 today · previous high £83 · all-time low £65

Springer Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical
Generating forecast…
£83.40 £62.79 £67.28 £71.78 £76.28 £80.78 £85.27 28 July 2026 14 August 2026 31 August 2026 17 September 2026 05 October 2026
View at Amazon ↗

Price data last checked 21 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 70 days • 2 price levels

Days at Price
Current Price
69 days 1 day · current 0 17 35 52 69 £65 £83 Days at Price

Price Analysis

Most common price: £65 (69 days, 98.6%)

Price range: £65 - £83

Price levels: 2 different prices over 70 days

Description

There is now evidence that irreversible brain damage accumulates very early in the course of multiple sclerosis. This book reviews the main neurobiological, magnetic resonance imaging, and clinical aspects of the early phases of the dis ease. Mechanisms ofirreversible axonal damage and the role played by the inter action of glia and the axon are highlighted. In contrast to what was believed for a long time, the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For reasons not understood, this remyelination process fails or does not start, particularly in the chronic stages ofthe disease. These findings emphasize the importance of the "milieu" changes induced by an inflammatory process in limiting remyelination. However, first indications are that part of this inflammatory process may have a neuroprotective effect. Pathological studies in multiple sclerosis have now clearly demonstrated that destructive processes may be followed by recovery phases in such a way that myelin may be morphologically and functionally reconstituted. These findings provide the rationale for early treatment and emphasize the importance of clinical trials in early multiple sclerosis. Early treatment is one of the most important aspects in multiple sclerosis today.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
06 February 2004
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Myelin Repair and Neuroprotection in Multiple Sclerosis
98% match

Myelin Repair and Neuroprotection in Multiple Sclerosis

Springer

£132.30 06 Oct 2026
Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)
98% match

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Springer

£106.15 04 Oct 2026
Myelin Repair and Neuroprotection in Multiple Sclerosis
98% match

Myelin Repair and Neuroprotection in Multiple Sclerosis

Springer

£88.21 20 Sep 2026
Multiple Sclerosis: Bench to Bedside - Global Perspectives
97% match

Multiple Sclerosis: Bench to Bedside - Global Perspectives

Springer

£111.64 04 Oct 2026
Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)

Elsevier

£62.82 02 Oct 2026
The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))
97% match

The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))

Cambridge University Press

£41.00 03 Oct 2026
Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)

Elsevier

£66.00 11 Sep 2026
International Review of Neurobiology,79: Volume 79
97% match

International Review of Neurobiology,79: Volume 79

Elsevier

£143.99 27 Sep 2026
Multiple Sclerosis: A Mechanistic View
97% match

Multiple Sclerosis: A Mechanistic View

Elsevier

£95.00 23 Sep 2026
Progressive Multiple Sclerosis
97% match

Progressive Multiple Sclerosis

Springer

£144.00 02 Oct 2026
Normal-appearing White and Grey Matter Damage in Multiple Sclerosis (Topics in Neuroscience)
97% match

Normal-appearing White and Grey Matter Damage in Multiple Sclerosis (Topics in Neuroscience)

Springer

£75.52 06 Oct 2026
Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases (Neuropsychiatric Symptoms of Neurological Disease)
97% match

Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases (Neuropsychiatric Symptoms of Neurological Disease)

Springer

£70.84 18 Sep 2026
Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases (Neuropsychiatric Symptoms of Neurological Disease)
97% match

Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases (Neuropsychiatric Symptoms of Neurological Disease)

Springer

£88.21 23 Sep 2026
Neurodegeneration in Multiple Sclerosis - Topics in Neurology
97% match

Neurodegeneration in Multiple Sclerosis - Topics in Neurology

Springer

£67.99 05 Oct 2026
Multiple Sclerosis Therapeutics
97% match

Multiple Sclerosis Therapeutics

CRC Press

£168.34 20 Aug 2026
Progressive Multiple Sclerosis - Springer Medical Reference
97% match

Progressive Multiple Sclerosis - Springer Medical Reference

Springer

£117.61 06 Oct 2026
Multiple Sclerosis Research Progress - Medical Reference
97% match

Multiple Sclerosis Research Progress - Medical Reference

£113.34 09 Oct 2026
Genes and Viruses in Multiple Sclerosis - Elsevier
97% match

Genes and Viruses in Multiple Sclerosis - Elsevier

Elsevier

£130.00 21 Oct 2026
Multiple Sclerosis Therapeutics
97% match

Multiple Sclerosis Therapeutics

Cambridge University Press

£102.72 07 Sep 2026
Multiple Sclerosis and Related Disorders: Handbook of Clinical Neurology: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab): ... (Handbook of Clinical Neurology, Volume 122)
97% match

Multiple Sclerosis and Related Disorders: Handbook of Clinical Neurology: Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab): ... (Handbook of Clinical Neurology, Volume 122)

Elsevier

£161.67 15 Aug 2026
Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)
97% match

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Springer

£113.76 30 Sep 2026
Handbook of Multiple Sclerosis
97% match

Handbook of Multiple Sclerosis

Foster Academics

£73.11 17 Sep 2026
Demyelinating Disorders of the Central Nervous System in Childhood (Cambridge Medicine (Hardcover))
97% match

Demyelinating Disorders of the Central Nervous System in Childhood (Cambridge Medicine (Hardcover))

Cambridge University Press

£59.77 09 Oct 2026
Multiple Sclerosis As A Neuronal Disease
97% match

Multiple Sclerosis As A Neuronal Disease

Elsevier

£65.34 04 Sep 2026